Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct;314(8):721-728.
doi: 10.1007/s00403-021-02274-3. Epub 2021 Sep 10.

Characterizing DRESS syndrome recurrence: a systematic review

Affiliations

Characterizing DRESS syndrome recurrence: a systematic review

Ajay N Sharma et al. Arch Dermatol Res. 2022 Oct.

Abstract

Recurrence of DRESS syndrome is poorly characterized, and dermatologists must be prepared to predict, identify, and manage patients after treatment of the initial presentation. In this study, a primary literature search was conducted using PubMed, capturing all articles recording cases of DRESS syndrome recurrence. Forty-two articles were included for review comprising a total of 60 patients. The average age of patients was 46.3 years and time to recurrence was 123 days. Recurrent episodes presented more frequently with a higher fever and eosinophil absolute peak. Relapse was most often attributed to the introduction of a new medication (n = 18). Of the 17 cases in which outcome data were available, the survival rate of those experiencing recurrence was 71%. Viral reactivation with HHV-6 and organ involvement of the liver were frequently recorded complications. In essence, viral reactivation, severe internal organ involvement, and hematological abnormalities all portended a poorer prognosis in those experiencing DRESS syndrome recurrence. An adequate course of treatment should be maintained until clinical and laboratory parameters normalize, with a slow taper to minimize the likelihood of relapse in those most at risk.

Keywords: DRESS; Drug hypersensitivity reaction; Drug reaction with eosinophilia and systemic symptoms; Eosinophilia; Inpatient; Recurrence.

PubMed Disclaimer

References

    1. Husain Z, Reddy BY, Schwartz RA (2013) DRESS syndrome: Part I. Clinical perspectives. J Am Acad Dermatol 68:693.e1-693.e14
    1. Bocquet H, Bagot M, Roujeau JC (1996) Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS). Semin Cutan Med Surg 15(4):250–257. https://doi.org/10.1016/s1085-5629(96)80038-1 - PubMed
    1. Choudhary S, McLeod M, Torchia D et al (2013) Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome. J Clin Aesthet Dermatol 6:31–37 - PubMed - PMC
    1. Criado PR, Criado RFJ, de Avancini JM et al (2012) Reacao a drogas com eosinofilia e sintomas sistemicos (DRESS)/sindrome da hipersensibilidade induzida por droga (DIHS): Revisao dos conceitos atuais. An Bras Dermatol 87:435–449 - PubMed
    1. Husain Z, Reddy BY, Schwartz RA (2013) DRESS syndrome: Part II. Management and therapeutics. J Am Acad Dermatol 68:709.e1-709.e9

Publication types

LinkOut - more resources